How Does One Treat Subretinal Neovascularization?

October 19, 2009

An article in Ophthalmology confirmed, to my relief, that it really doesn’t matter what kind of subretinal neovascularization (SRN) one is dealing with- classic, minimally classic, occult. What counts is the initial vision when determining how these lesions behave. And with the advent of VEGF, we inject all these lesions no matter what. Remember when as residents we had to study these lesions with a fine tooth comb to figure out what percentage was classic or not classic? And retinologists had to make these kinds of determinations in order to get approval for payment for PDT?




Jump down to form below to submit your own comments

2 Responses to “How Does One Treat Subretinal Neovascularization?”

  • If anyone is interested in the early history of PDT and other laser treatments for AMD, I wrote about these starting in December 1994, in a series of three articles for OSN. They are now posted on my online Journal:

    Photodynamic Therapy for Macular Degeneration

    Laser Treatments for AMD Show Promise


    Visudyne Looks Promising for Treating Wet AMD

    Then I switched over and started tracking Avastin in Jan. 2006:

    Avastin: A New Hope for Treating AMD

  • You got it! I agree whole heartedly. Give PDT a break though. Remember, this was the first time we could offer any possibility of a positive outcome.

    Anti-VEGF therapy really has changed our “world.”